Platinum Sponsors

KMM Group

Spectrum Plastics

Steri-Tek


Silver Sponsors

Able Electropolishing

Arthur G Russell

Cyient

Eldon James

Elmas Medical

Eurofins

Forefront

IQMS

IRP Medical

J-Pac

Kistler

KP

Laser Light

MedBio

MTD Micromolding

MW Medical Solutions


Supporting Organizations

EDC Utah

Governor's Office of Economic Development


Gold Sponsors

B Braun

Natvar

NDH Medical

Trademark Plastics


Silver Sponsors

Nelson Labs

Plastikos

Quality, Microbiology & Sterilization Services

RAUMEDIC

RJG

Roechling Medical

STI/McLean

Tegra Medical

Teleflex Medical OEM

Triangle

Vance Street Capital

Viant

Wytech


Bronze Sponsors

Accu-Tube

AIP Precision Manufacturing

maxon

Kelvyn H. Cullimore Jr.

Kelvyn H. Cullimore Jr., President and CEO, BioUtah
Kelvyn H. Cullimore Jr. was named president and CEO of BioUtah, the state trade association for life science companies in Utah, in October 2018. In that capacity, he also serves on the board of the World Trade Center Utah and on the advisory board of the Center for Medical Innovation at the University of Utah. From 1992 to 2018, Cullimore was the president and CEO of Dynatronics Corporation, a manufacturer of physical therapy devices and products with an international reach. Dynatronics is a publicly traded, Cottonwood Heights, Utah-based company originally founded by Cullimore and his father in 1979. He served on the Board of Directors for Dynatronics until December 2019. From 2003 to 2016, Cullimore served on the Board of Directors of the Medical Device Manufacturers Association headquartered in Washington, D.C. He is a past Trustee of the Utah Technology Council, an industry association which, at the time, included life science and high-tech companies.

Dr. Michael Drues

Michael Drues, Ph.D., President, Vascular Sciences
Michael Drues, Ph.D., is president of Vascular Sciences, an education, training, and consulting company offering a broad range of services to medical device, pharmaceutical, and biotechnology companies including stimulating and innovative educational programing, creative regulatory strategy and completive regulatory intelligence, regulatory submission design, FDA presentation preparation and defense, brainstorming sessions, prototype design, product development, benchtop and animal testing, clinical trial design, reimbursement, clinical acceptance, business development, and technology assessment. Dr. Drues received his B.S., M.S., and Ph.D. degrees in Biomedical Engineering from Iowa State University in Ames, Iowa. He has worked for and consulted with leading medical device, pharmaceutical, and biotechnology companies ranging in size from start-ups to Fortune 100 companies. He also works on a regular basis for the U.S. Food and Drug Administration (FDA), Health Canada, the U.S. and European Patent Offices, the Centers for Medicare and Medicaid Services (CMS), and other regulatory and governmental agencies around the world.

Tony Freeman

Anthony S. Freeman, President, A.S. Freeman Advisors LLC
Tony Freeman leads A. S. Freeman Advisors, a transaction advisory firm focused on the precision manufacturing and specialty materials industries. With a focus on supply chain companies, Freeman Advisors offers buy-side and sell-side services as well as strategic consulting on market selection and value enhancement. Clients range from Fortune 500 firms to small, privately held companies in the life sciences, aerospace, electronics, and specialty chemical industries. Freeman also serves as executive director of mdmX, an industry organization for medical supply chain executives. He is a regular contributor to MPO and other industry publications. He holds a BA from the University of Chicago and an MBA from Columbia University.

Dawn Lissy

Dawn Lissy, President & Co-Founder, Empirical Technologies Corp.
Dawn Lissy is a biomedical engineer, entrepreneur, and innovator. Since 1998, Empirical Technologies Corp. has operated under Lissy’s direction. Empirical offers the full range of regulatory and quality systems consulting, testing, small batch and prototype manufacturing, and validations services to bring a medical device to market. Empirical is very active within ASTM and has one of the widest scopes of test methods of any accredited independent lab in the United States. Since Lissy was a member of the FDA’s Entrepreneur-in-Residence program, she has first-hand, in-depth knowledge of the regulatory landscape. Lissy holds an inventor patent for the Stackable Cage System for corpectomy and vertebrectomy. Her M.S. in biomedical engineering is from The University of Akron, Ohio.

David Mabie

David Mabie, VP—Business Development, Providien LLC
Dave Mabie is VP of business development at Providien, a contract manufacturer of medical devices. He started his 25-year span in the life sciences industry in technical sales of medical raw materials, later moving into program management, marketing, and director roles for injection molded components and manufacturing of Class ll and Class lll disposable medical devices. Mabie has spent the past 14 years serving as vice president, business development for outsourced manufacturers ATEK Medical (exited to VENTION Medical 2011), followed by Providien (exited to Carlisle CIT 2019) where he assisted large and small medical device companies transferring manufacturing within the U.S. and to Costa Rica and Mexico for improved quality, lower cost of manufacturing, and reduction of supply chain. To meet demand during his time at ATEK, the company expanded capacity by adding one new manufacturing facility in the United States and two in Costa Rica. In 2010, ATEK was named by Inc. Magazine as a U.S. Top 500 growth company. Mabie serves as an advisor to leading investment banking companies looking to invest in the medical device contract manufacturing arena and has served as a senior advisor to FOXCONN Medical, division of FOXCONN, the world’s largest electro-mechanical services provider. He received his BS in Business Administration from the University of Southern California.

Adeeb Mahmud

Adeeb Mahmud, Managing Director, FSG
Adeeb Mahmud is a managing director at FSG, where he leads projects on corporate social impact, global development, and philanthropy. He joined FSG in 2006, is a member of the firm’s leadership team, and also leads FSG’s Washington, D.C. office. He brings 15 years of experience in private sector consulting and global development. Mahmud has led corporate philanthropy, corporate responsibility, and shared value engagements with companies across industries, including Abbott, Sanofi, Merck, Novo Nordisk, Mastercard, and Dow Chemical. As part of these and other projects, Adeeb has conducted field-work in Brazil, Ethiopia, India, Israel, Mexico, Nigeria, Rwanda, Saudi Arabia, South Africa, and Uganda. Other engagements include advising USAID-funded collective impact efforts in Uganda and Cambodia, developing shared value corporate partnership opportunities for Save the Children USA, and identifying ways to accelerate access for drugs, diagnostics, and vaccines on behalf of the Bill & Melinda Gates Foundation. Before FSG, Mahmud worked in business development of a start-up biotechnology company in Boston. Previously, he was a management consultant working with global healthcare clients. Mahmud holds a Master’s in public policy from Harvard University’s John F. Kennedy School of Government, where he was selected as a Reynolds Fellow for social entrepreneurship, and a Bachelor’s, cum laude, from Middlebury College.

Tony Mulone

Tony Mulone, President, Winstable Group LLC
Tony Mulone is current president of Winstable Group LLC, a medical device consulting firm with the goal of bridging contract manufacturers with OEMs. Previously, he was VP/general manager for the Custom Product Solutions (CPS) division of Covidien, a 12-billion dollar medical device company. While there, Mulone was responsible for directing the strategic growth into non-hospital markets, which included medical/pharma OEM, animal health, dental, and rehabilitation. The CPS group focused its efforts on providing custom solutions, centering their attention on promoting Covidien product brands into these emerging markets. Mulone is also currently chairman of the board for Signati Medical Inc. and is a board member for Sharps Technology Inc. He began his medical device career with Instrumentation Laboratories and then joined Kendall/Tyco Healthcare/Covidien/Medtronic, holding management positions in manufacturing, marketing, and sales. He holds a Bachelor’s degree in economics from Framingham State University (Mass.). He also holds a USGC Masters Captains license.

Dr. Bryce Rutter

Bryce G. Rutter Ph.D., Founder and CEO, Metaphase Design Group Inc.
Dr. Bryce Rutter, founder and CEO of Metaphase Design Group Inc., is a leading expert in the research, ergonomics, and design of medical products and a worldwide specialist in hand-intensive products and packaging. His work includes collaborations with numerous global prestigious brands and high-profile start-ups on products ranging from robotic surgical systems, powered and manual instrument design, and drug delivery systems to disposables, mobile and wearable devices, to personal care products, IFUs, and usability and contextual inquiry research programs. Metaphase delivers innovative designs that redefine industry standards, invigorate sleepy brands, and create new product categories. Under Dr. Rutter’s leadership, Metaphase has received more than 120 international design excellence awards and 117 patents. Dr. Rutter holds degrees in industrial design and a Ph.D. in kinesiology, specializing in hand function.